首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Pathology >miR-135a acts as a tumor suppressor by targeting ASPH in endometrial cancer
【2h】

miR-135a acts as a tumor suppressor by targeting ASPH in endometrial cancer

机译:miR-135a通过靶向子宫内膜癌中的ASPH来抑制肿瘤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Endometrial cancer (EC) ranks as the fourth most commonly diagnosed cancer type in women worldwide. MicroRNAs (miRNAs) are important regulators with crucial roles in regulating diverse biologic processes, including tumor initiation and progression. Previous studies have demonstrated that miR-135a was correlated with tumorigenesis in various cancers. However, its expression and biologic role in EC remained to be determined. This study aimed to clarify whether miR-135a acts as a tumor suppressor in EC by regulating the expression of aspartate-β-hydroxylase (ASPH). Expression of miR-135a was measured by qRT-PCR and the results demonstrated that miR-135a was downregulated in EC cell lines compared to a normal cell line. Cell counting kit-8 (CCK-8) and wound-healing assays demonstrated that overexpression of miR-135a significantly inhibited cell proliferation and migration. Online prediction algorithm and dual luciferase activity reporter assay revealed that ASPH acts as a direct target of miR-135a. ASPH expression was downregulated in EC cell lines when miR-135a was overexpressed. Collectively, our results indicate that miR-135a targets ASPH to inhibit EC cell proliferation and migration, suggesting a tumor suppressive role of miR-135a in EC.
机译:子宫内膜癌(EC)在全球女性中被列为第四大最常被诊断出的癌症类型。微小RNA(miRNA)是重要的调节因子,在调节多种生物过程(包括肿瘤的发生和发展)中起着至关重要的作用。先前的研究表明,miR-135a与多种癌症的肿瘤发生有关。但是,其在EC中的表达和生物学作用仍有待确定。本研究旨在通过调节天冬氨酸-β-羟化酶(ASPH)的表达来阐明miR-135a是否在EC中起肿瘤抑制作用。通过qRT-PCR测量miR-135a的表达,结果表明与正常细胞系相比,miR-135a在EC细胞系中被下调。细胞计数试剂盒8(CCK-8)和伤口愈合分析表明,miR-135a的过表达显着抑制细胞增殖和迁移。在线预测算法和双重荧光素酶活性报告基因检测表明,ASPH充当miR-135a的直接靶标。当miR-135a过表达时,ECH细胞系中的ASPH表达下调。总的来说,我们的结果表明miR-135a靶向ASPH以抑制EC细胞增殖和迁移,提示miR-135a在EC中具有肿瘤抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号